Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 5, 2009, Pages 936-942

  Kamar, Nassim ^a,b,c   Glander, Petra ^a   Nolting, Jochen ^a   Böhler, Torsten ^a,c   Hambach, Pia ^a   Liefeldt, Lutz ^a   Rostaing, Lionel ^b   Neumayer, Hans Hellmut ^a   Budde, Klemens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; INOSINATE DEHYDROGENASE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; IMPDH1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TRANSFERRIN RECEPTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; IC 50; KIDNEY TRANSPLANTATION; LYMPHOCYTE FUNCTION; MALE; MAXIMUM PLASMA CONCENTRATION; PHARMACODYNAMICS; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; BIOLOGICAL MODEL; BLOOD; CELL DIVISION; CLINICAL TRIAL; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PREOPERATIVE CARE;

ADULT; ANTIGENS, CD; CELL DIVISION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYCOPHENOLIC ACID; PREOPERATIVE CARE; RECEPTORS, TRANSFERRIN; T-LYMPHOCYTES; YOUNG ADULT;

EID: 67649398251     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04860908     Document Type: Article

References (29)

1. Klupp J, Holt DW, van Gelder T: How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients. Transpl Immunol 9: 211-214, 2002
2. Dambrin C, Klupp J, Morris RE: Pharmacodynamics of immunosuppressive drugs. Curr Opin Immunol 12: 557-562, 2000
3. Halloran PF, Helms LM, Kung L, Noujaim J: The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68: 1356-1361, 1999
4. Grinyo JM, Cruzado JM, Millan O, Caldes A, Sabate I, Gil-Vernet S, Seron D, Brunet M, Campistol JM, Torras J, Martorell J: Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts. Transplantation 78: 1400-1403, 2004
5. Glander P, Braun KP, Hambach P, Bauer S, Mai I, Roots I, Waiser J, Fritsche L, Neumayer HH, Budde K: Non-radioactive determination of inosine 5′-monophosphate dehydrogenase (IMPDH) in peripheral mononuclear cells. Clin Biochem 34: 543-549, 2001
6. Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE: Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: Inhibition by immunosuppressive drugs in vitro. J Immunol Methods 253: 95-112, 2001
7. Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Morris RE: Novel assays of multiple lymphocyte functions in whole blood measure: New mechanisms of action of mycophenolate mofetil in vivo. Transpl Immunol 10: 1-14, 2002
8. Bohler T, Nolting J, Kamar N, Gurragchaa P, Reisener K, Glander P, Neumayer HH, Budde K, Klupp J: Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Ther Drug Monit 29: 77-86, 2007
9. Glander P, Hambach P, Braun KP, Fritsche L, Giessing M, Mai I, Einecke G, Waiser J, Neumayer HH, Budde K: Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation. Am J Transplant 4: 2045-2051, 2004
10. Gummert JF, Barten MJ, Sherwood SW, van Gelder T, Morris RE: Pharmacodynamics of immunosuppression by mycophenolic acid: Inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther 291: 1100-1112, 1999
11. Gummert JF, Barten MJ, van Gelder T, Billingham ME, Morris RE: Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology. Transplantation 70: 1038-1049, 2000
12. Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, Morris RE: Pharmacodynamics of mycophenolate mofetil after heart transplantation: New mechanisms of action and correlations with histologic severity of graft rejection. Am J Transplant 2: 719-732, 2002
13. Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE: Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection. J Heart Lung Transplant 23: 334-351, 2004
14. Kamar N, Glander P, Nolting J, Bohler T, Hambach P, Liefeldt L, Neumayer HH, Klupp J, Budde K: Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation. Transplant Proc 38: 2292-2294, 2006
15. Quemeneur L, Flacher M, Gerland LM, Ffrench M, Revillard JP, Bonnefoy-Berard N: Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. J Immunol 169: 2747-2755, 2002
16. Sankatsing SU, Prins JM, Yong SL, Roelofsen J, van Kuilenburg AB, Kewn S, Back DJ, Bemelman FJ, ten Berge IJ: Mycophenolate mofetil inhibits T-cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP. Transpl Int 21: 1066-1071, 2008
17. Bohler T, Canivet C, Le Nguyen PN, Galvani S, Thomsen, Durand D, Salvayre R, Nègre-Salvayre A, Rostaing L, Kamar, N: Cytokines correlate with age in healthy volunteers, dialysis patients and kidney -transplant patients. Cytokines 45: 169-173, 2009
18. Hayes GR, Williams A, Costello CE, Enns CA, Lucas JJ: The critical glycosylation site of human transferrin receptor contains a high-mannose oligosaccharide. Glycobiology 5: 227-232, 1995
19. Laurent AF, Dumont S, Poindron P, Muller CD: Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Exp Hematol 24: 59-67, 1996
20. Catapano CV, Dayton JS, Mitchell BS, Fernandes DJ: GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Mol Pharmacol 47: 948-955, 1995
21. Mustelin T: GTP dependence of the transduction of mitogenic signals through the T3 complex in T lymphocytes indicates the involvement of a G-protein. FEBS Lett 213: 199-203, 1987
22. Forrest TL, Ware RE, Howard T, Jaffee BD, Denning SM: Novel mechanisms of brequinar sodium immunosuppression on T cell activation. Transplantation 58: 920-926, 1994
23. Fairbanks LD, Bofill M, Ruckemann K, Simmonds HA: Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J Biol Chem 270: 29682-29689, 1995
24. Qiu Y, Fairbanks LD, Ruckermann K, Hawrlowicz CM, Richards DF, Kirschbaum B, Simmonds HA: Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human Tlymphocytes. Transplantation 69: 890-897, 2000
25. Glander P, Hambach P, Braun KP, Fritsche L, Waiser J, Mai I, Neumayer HH, Budde K: Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients. Int J Clin Pharmacol Ther 41: 470-476, 2003
26. Budde K, Braun KP, Glander P, Bohler T, Hambach P, Fritsche L, Waiser J, Mai I, Neumayer HH: Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients. Transplant Proc 34: 1748-1750, 2002
27. Budde K, Glander P, Braun KP, Bohler T, Waiser J, Fritsche L, Mai I, Neumayer H: Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients. Transplant Proc 33: 3313-3315, 2001
28. Langman LJ, LeGatt DF, Halloran PF, Yatscoff RW: Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation 62: 666-672, 1996
29. Vethe NT, Mandla R, Line PD, Midtvedt K, Hartmann A, Bergan S: Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment. Scand J Clin Lab Invest 66: 31-44, 2006